Literature DB >> 14749622

Palliative care in pancreatic cancer.

Frank J Brescia1.   

Abstract

BACKGROUND: Pancreatic cancer is a formidable health problem, representing the 10th most common malignancy in the United States and the 4th most common cause of all cancer deaths. The overall 5-year survival rate is 4%, making this disease a model tumor in which to address the specialized care issues of palliative medicine.
METHODS: General considerations in both medical decision-making and symptom management are reviewed. Treatment of patients with locally unresectable, recurrent, or metastatic disease is individualized, based on considerations that include patient age, patient wishes, family influence, insurance constraints, and geographic practice variations.
RESULTS: Success in managing progressive symptoms is needed to palliate patients with advanced pancreatic cancer. Common problems include biliary obstruction, depression, pain, intestinal obstruction, and fatigue.
CONCLUSIONS: Relief of pain and suffering associated with critical illness is required in managing patients with cancer. Pancreatic cancer is a model illness that mandates this need.

Entities:  

Mesh:

Year:  2004        PMID: 14749622     DOI: 10.1177/107327480401100206

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  7 in total

1.  A cognitive behavioral intervention for symptom management in patients with advanced cancer.

Authors:  Paula Sherwood; Barbara A Given; Charles W Given; Victoria L Champion; Ardith Z Doorenbos; Faouzi Azzouz; Sharon Kozachik; Kim Wagler-Ziner; Patrick O Monahan
Journal:  Oncol Nurs Forum       Date:  2005-11-03       Impact factor: 2.172

2.  Is diabetes a risk factor for central venous access port-related bloodstream infection in oncological patients?

Authors:  A Touré; P Vanhems; C Lombard-Bohas; J-C Souquet; M Lauverjat; C Chambrier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-22       Impact factor: 3.267

3.  Metastatic pancreatic cancer: abdominal pain in a 22-year-old woman.

Authors:  Bakul T Roy; Roshan B Roy
Journal:  BMJ Case Rep       Date:  2015-11-26

4.  Thermal therapy of pancreatic tumours using endoluminal ultrasound: Parametric and patient-specific modelling.

Authors:  Matthew S Adams; Serena J Scott; Vasant A Salgaonkar; Graham Sommer; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2016-01-21       Impact factor: 3.914

5.  A prospective, randomized, double-blind, placebo controlled trial on the efficacy of ethanol celiac plexus neurolysis in patients with operable pancreatic and periampullary adenocarcinoma.

Authors:  Harish Lavu; Harry B Lengel; Naomi M Sell; Joseph A Baiocco; Eugene P Kennedy; Theresa P Yeo; Sherry A Burrell; Jordan M Winter; Sarah Hegarty; Benjamin E Leiby; Charles J Yeo
Journal:  J Am Coll Surg       Date:  2014-12-17       Impact factor: 6.113

6.  Fabrication of a silver particle-integrated silicone polymer-covered metal stent against sludge and biofilm formation and stent-induced tissue inflammation.

Authors:  Tae Hoon Lee; Bong Seok Jang; Min Kyo Jung; Chan Gi Pack; Jun-Ho Choi; Do Hyun Park
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

7.  Theoretical investigation of transgastric and intraductal approaches for ultrasound-based thermal therapy of the pancreas.

Authors:  Serena J Scott; Matthew S Adams; Vasant Salgaonkar; F Graham Sommer; Chris J Diederich
Journal:  J Ther Ultrasound       Date:  2017-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.